NAT-EVEROLIMUS

natco pharma (canada) inc🇨🇦 Health Canada

Approval Id: 7cfbb3ec862c05cb
Drug Approval Canada Name: NAT-EVEROLIMUS
Product Name: NAT-EVEROLIMUS
Status: Marketed
Status Date: 2023-04-05
Original Market Date: 2023-04-05
Din: 02530090
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 10:00.00
Atc Original: L04AH02 EVEROLIMUS
Atc Name: l 04 ah 02
Aig Number: 0152682003
Company Name: natco pharma (canada) inc
Company Address: 2000 Argentia Road, Plaza 1, Suite 200, Mississauga, Ontario, Canada, L5N 1P7

EVEROLIMUS

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7cfbb3ec862c05cb

Type

Standard